CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 20186-20528 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T189","span":{"begin":0,"end":342},"obj":"Sentence"},{"id":"T87613","span":{"begin":0,"end":342},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Most isolates showed decreased susceptibility to tetracycline, minocycline, erythromycin, and quinupristin-dalfopristin (95%, 94%, 80%, 54%, respectively), and to a lesser extent to high-level of resistance (HLR) of streptomycin, nitrofurantoin, ciprofloxacin, HLR to gentamicin, chloramphenicol and ampicillin (52%, 33%, 32%, 21%, 11%, 10%)."}

{"project":"CORD-PICO","denotations":[{"id":"p1_all87","span":{"begin":49,"end":119},"obj":"Intervention"},{"id":"p1_all88","span":{"begin":182,"end":264},"obj":"Outcome"},{"id":"p1_all89","span":{"begin":268,"end":310},"obj":"Intervention"},{"id":"p2_i24","span":{"begin":49,"end":61},"obj":"Pharmacological"},{"id":"p2_i25","span":{"begin":63,"end":74},"obj":"Pharmacological"},{"id":"p2_i26","span":{"begin":76,"end":88},"obj":"Pharmacological"},{"id":"p2_i27","span":{"begin":94,"end":119},"obj":"Pharmacological"},{"id":"p2_i28","span":{"begin":246,"end":259},"obj":"Pharmacological"},{"id":"p2_i29","span":{"begin":268,"end":278},"obj":"Pharmacological"},{"id":"p2_i30","span":{"begin":280,"end":295},"obj":"Pharmacological"},{"id":"p2_i31","span":{"begin":300,"end":310},"obj":"Pharmacological"}],"text":"Most isolates showed decreased susceptibility to tetracycline, minocycline, erythromycin, and quinupristin-dalfopristin (95%, 94%, 80%, 54%, respectively), and to a lesser extent to high-level of resistance (HLR) of streptomycin, nitrofurantoin, ciprofloxacin, HLR to gentamicin, chloramphenicol and ampicillin (52%, 33%, 32%, 21%, 11%, 10%)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T189","span":{"begin":0,"end":342},"obj":"Sentence"}],"text":"Most isolates showed decreased susceptibility to tetracycline, minocycline, erythromycin, and quinupristin-dalfopristin (95%, 94%, 80%, 54%, respectively), and to a lesser extent to high-level of resistance (HLR) of streptomycin, nitrofurantoin, ciprofloxacin, HLR to gentamicin, chloramphenicol and ampicillin (52%, 33%, 32%, 21%, 11%, 10%)."}